Three of top five pharmaceutical companies by market share based in India
In May, price growth for drugs was in negative territory at (-)1 per cent
The high dependence on Chinese imports has also been dubbed as a health security risk
DPCO 2013 that lists drugs under price control already includes 18 per cent drugs sold in domestic market
Branded generics occupies 90% of the Rs 1-lakh cr pharma market in India
The authority maintained that it was witnessing a large number of non-compliance cases every month
NPPA has till date recovered only 7.8 per cent of fines related to overpricing; dues run in to Rs 3,698.32 crore